Twist Bioscience (NASDAQ:TWST)报告其季度每股亏损为$(0.53)，这比分析师预期的$(0.64)高出17.19%。相比去年的每股亏损$(0.75)，增加了29.33%。公司报告季度销售额为$88.71百万，超过了分析师预期的$86.97百万，增幅为2.00%。这比去年同期的销售额$71.50百万增加了24.08%。
以上内容来自Benzinga Earnings专栏，原文如下：
Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.64) by 17.19 percent. This is a 29.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $88.71 million which beat the analyst consensus estimate of $86.97 million by 2.00 percent. This is a 24.08 percent increase over sales of $71.50 million the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。